Coagulation challenges after severe injury with hemorrhagic shock

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 6, 2012, Pages 1714-1718

  Ledgerwood, Anna M ^a   Blaisdell, William ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOCAPROIC ACID; ANTITHROMBIN III; BICARBONATE; FRESH FROZEN PLASMA; GABEXATE; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE;

ACIDOSIS; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD VISCOSITY; BLOOD VOLUME; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; FIBRINOLYSIS; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; KIDNEY FAILURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; RESUSCITATION; SENSITIVITY AND SPECIFICITY; SNAKEBITE; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HEMOSTASIS, SURGICAL; HEMOSTATIC TECHNIQUES; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; MALE; MULTIPLE TRAUMA; PLASMA; RISK ASSESSMENT; SHOCK, HEMORRHAGIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84864535408     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318245225c     Document Type: Article

References (19)

1. Heinback DM. Hemostasis in massively transfused trauma patients. In: Fresh Frozen Plasma: Indications and Risk. Bethesda, MD: NIH Consensus Development Conference; 1984:3839.
2. Lucas CE, Denis R, Ledgerwood AM, Grabow D. The effects of Hespan on serum and lymphatic albumin, globulin, and coagulant protein. Ann Surg. 1988;207:416-420.
3. Ledgerwood AM, Lucas CE. A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma. 2003;54: S68-S74.
4. Lucas CE, Ledgerwood AM. Physiology of colloid-supplemental resuscitation from shock. J Trauma. 2003;54:S75-S81.
5. Swisher SN. Overview of fresh frozen plasma. In: Fresh Frozen Plasma: Indications and Risk. Bethesda, MD: NIH Consensus Development Conference; 1984:13-18.
6. Lucas CE, Ledgerwood AM, Saxe JM, Dombi G, Lucas WF. Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock. Am J Surg. 1996;171:399-404.
7. Harrigan C, Lucas CE, Ledgerwood AM, Walz DA, Mammen EF. Serial changes in primary hemostasis after massive transfusion. Surgery. 1985;98: 836-843.
8. Harrigan C, Lucas CE, Ledgerwood AM. The effect of hemorrhagic shock on the clotting cascade in injured patients. J Trauma. 1989;29: 1416-1422.
9. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 1007;52:307-310.
10. McKay DG. Trauma and disseminated intravascular coagulation. J Trauma. 1969;9:646-660.
11. McKay DG, Muller-Beghaus G. Therapeutic indications of disseminated intravascular coagulation. Am J Cardiol. 1967;20:392.
12. Cafferata HT, Aggeler PM, Robinson AJ, Blaisdell FW. Intravascular coagulation in the surgical patient: its significance in diagnosis. Am J Surg. 2969:118:281-291.
13. Baker WF. Clinical aspects of disseminated intravascular coagulation: a clinician's point of view. Semin Thromb Hemost. 1989;15:1-57.
14. Ali G, Kak M, Kumar M, et al. Acute renal failure following echis carinatus (saw-scaled viper) envenomization. Indian J Nephrol. 2002;14:177-181.
15. Hewson W. The Properties of the Blood. London: 1972.
16. Delshammar M, Lasson A, Nilsson LM, Ohlsson K, Wallmark A, Vernersson E. Abnormal proteolysis (DIC)-successful treatment with antithrombin III concentrate and a concentrate containing FXIII and native von Willebrand factor. J Intern Med. 1989;225:21-27.
17. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447-458.
18. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind chemical trials. J Trauma. 2005;59:8-15.
19. Yuksel M, Okajima K, Uchiba M, Okabe H. Gabexate mesilate, a synthetic inhibitor inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor-KB and activator protein-1 in human monocytes. J Pharmacol Exp Ther. 2003;305:298-305.